Skip to main content

Table 4 Characteristics of female patients with VA according to BMI

From: Sex differences in clinical characteristics and long-term outcomes in patients with vasospastic angina: results from the VA-Korea registry, a prospective multi-center cohort

Characteristic

BMI < 25 kg/m2 (n = 364)

BMI ≥ 25 kg/m2 (n = 303)

p

Age, years

56.3 ± 10.9

57.7 ± 10.4

0.036

BMI, kg/m2

22.2 ± 1.7

27.9 ± 3.4

< 0.001

Systolic blood pressure, mmHg

124 ± 19

123 ± 17

0.634

Diastolic blood pressure, mmHg

75.4 ± 12.3

74.1 ± 10.8

0.173

Cardiovascular risk factors

 Hypertension

111 (30.5)

141 (46.5)

< 0.001

 Diabetes mellitus

16 (4.4)

37 (12.2)

< 0.001

 Dyslipidemia

55 (15.2)

66 (21.9)

0.026

 Current smoking

24 (6.6)

10 (3.3)

0.170

 Alcohol drinking

66 (18.1)

36 (11.9)

0.026

Clinical diagnosis

 Acute myocardial infarction

5 (1.4)

4 (1.3)

0.960

 Cardiac arrest

3 (0.8)

2 (0.7)

0.999

 Syncope

2 (0.5)

2 (0.7)

0.999

 Ventricular tachycardia or fibrillation

2 (0.5)

1 (0.3)

0.999

Significant atherosclerosis

29 (8.0)

27 (9.0)

0.642

Definite spasm

88 (24.2)

83 (27.4)

0.343

Laboratory findings

 Hemoglobin, g/dL

12.7 ± 1.2

12.9 ± 1.2

0.147

 GFR, mL/min/1.73 m2

104 ± 48

100 ± 29

0.136

 Glucose, mg/dL

105 ± 38

107 ± 31

0.502

 Total cholesterol, mg/dL

178 ± 34

177 ± 37

0.710

 LDL cholesterol, mg/dL

105 ± 30

107 ± 32

0.639

 HDL cholesterol, mg/dL

52.4 ± 13.7

48.0 ± 11.7

< 0.001

 Triglyceride, mg/dL

115 ± 101

132 ± 74

0.019

 Left ventricular ejection fraction, %

64.4 ± 6.2

65.2 ± 6.4

0.126

Discharge medications

 Antiplatelet

138 (38.2)

141 (46.5)

0.030

 Non-DHP calcium channel blocker

282 (77.5)

222 (73.3)

0.208

 Nitrate

281 (77.2)

241 (79.5)

0.466

 RAS blocker

45 (12.4)

56 (18.5)

0.028

 Statin

156 (42.9)

153 (50.5)

0.049

  1. Numbers are represented as mean ± SD or n (%). VA Vasospastic angina, BMI Body mass index, GFR Glomerular filtration rate, LDL Low-density lipoprotein, HDL High-density lipoprotein, DHP Non-dihydropyridine, RAS Renin-angiotensin system